Literature DB >> 3494596

Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.

K L Insogna, E C Weir, T L Wu, A F Stewart, A E Broadus, W J Burtis, M Centrella.   

Abstract

Humoral hypercalcemia of malignancy (HHM) is caused by a circulating bone-resorbing factor or factors. Suggestions as to the nature of this factor include PTH-like proteins, transforming growth factors, and bone-resorbing factors distinct from either of the first two classes of polypeptides. We investigated the occurrence of these three activities in a highly purified extract of the H-500 Leydig cell tumor which causes HHM when implanted into Fisher rats. PTH-like adenylate cyclase-stimulating activity (ACSA) was extracted from tumor tissue by sequential treatment with urea/HCl and ethanol/NaCl. Tumor extract was further purified by hydrophobic-interaction, gel-filtration, and reverse-phase HPLC steps to a specific activity of 1038 ng eq bPTH(1-34)/mg protein. Only the fraction pool containing ACSA demonstrated significant bone-resorbing (1.78-fold over basal) and transforming growth factor activity (epidermal growth factor (EGF)-dependent colony formation in soft agar suspension by NRK-49F indicator cells). A subsequent reverse-phase HPLC step produced material which contained both ACSA and transforming growth factor beta (TGF beta)-like activity in a single fraction. Whether the responsible mediator in this animal model has TGF beta-like properties as well as PTH-like and bone-resorbing activity remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494596     DOI: 10.1210/endo-120-5-2183

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

Authors:  A F Stewart; M Mangin; T Wu; D Goumas; K L Insogna; W J Burtis; A E Broadus
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Native and a synthetic analogue of the malignancy-associated parathyroid hormone-like protein have in vitro transforming growth factor-like properties.

Authors:  K L Insogna; A F Stewart; C A Morris; L M Hough; L M Milstone; M Centrella
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.

Authors:  Iori Motoo; Sohachi Nanjo; Takayuki Ando; Satoshi Yamashita; Toshikazu Ushijima; Ichiro Yasuda
Journal:  Gastric Cancer       Date:  2021-09-23       Impact factor: 7.370

Review 4.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

Review 5.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.

Authors:  P J Kostenuik; G Singh; K L Suyama; F W Orr
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

7.  Adenylate cyclase-stimulating, bone-resorbing and B TGF-like activities in canine apocrine cell adenocarcinoma of the anal sac.

Authors:  E C Weir; M Centrella; R E Matus; M L Brooks; T Wu; K L Insogna
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

8.  Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro.

Authors:  J R Werkmeister; E A Blomme; M T Weckmann; A Gröne; L K McCauley; A B Wade; J O'Rourke; C C Capen; T J Rosol
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

Review 9.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.